Teprosulvose , CAS No.1983131-47-0

CAS: 1983131-47-0 Cat. No.: T1444392 Fórmula: C₂₇H₅₂O₁₀S Peso molecular: 568.76

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Visão geral

Teprosulvose is a radiosensitizer.

Specifications

Condições de armazenamento de armazenamento

Store at -20°C

Enviado em

Ice chest + Ice pads

Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.

Nomes e identificadores

Peso molecular

568.76

Application Protocols

No validated application protocols are provided in the current product data for Teprosulvose.

• Tested applications (e.g., WB, IHC, IF, FC, ELISA), recommended working dilutions, positive controls, and sample preparation guidance are all: Not specified for this item; refer to CoA/Spec Sheet.

General recommendations (when no protocol is supplied):

• If using in cell-based assays, begin with a vehicle-only control series and a broad concentration range (e.g., 0.01–50 µM equivalent if soluble) to establish a no-effect and solubility limit; adjust based on observed cytotoxicity or assay interference.
• For biochemical assays, prepare fresh working solutions, verify activity readouts are not confounded by solvent or intrinsic absorbance/fluorescence of the compound, and include orthogonal detection if possible.
• Document lot number, preparation time, storage conditions, and freeze–thaw counts to ensure reproducibility.

Please consult the CoA/Spec Sheet or request a technical note for any product-specific application details.

Biological Roles

Biological function, targets, and pathway roles for Teprosulvose are not provided in the current product data.

• No mechanism-of-action, target class, or pathway annotations are supplied. Any presumed role in metabolism, signaling, or structural biology cannot be asserted without primary data.
• If you intend to use this reagent in biochemical or cell-based experiments, first establish baseline compatibility (vehicle control, concentration-response titration, off-target checks) and verify stability in the intended buffer, temperature, and time frame.

General considerations for life science reagents (non-clinical):

• Assess adsorption losses to plastics vs. glass, particularly at low concentrations; include carrier proteins (e.g., 0.1% BSA) only if compatible and not interfering with readouts.
• Confirm that assay readouts (fluorescence, absorbance, luminescence) are not directly influenced by the compound (inner-filter effects, quenching, or intrinsic fluorescence).
• Perform control experiments for solvent effects (e.g., DMSO-only controls) and pH/ionic strength sensitivity if buffers vary across experiments.

Please consult the product’s CoA/Spec Sheet or contact Technical Support for any available biology-focused notes or literature cross-references for CAS 1983131-47-0.

Buffer Applications

No buffer system guidance is specified for Teprosulvose. Its acid/base properties, ionic state, and compatibility with common buffers are unknown from the listing.

General buffer-handling guidance (if preparing assay solutions):

• Prepare a concentrated stock in a compatible solvent (often DMSO or water), filter-sterilize if needed (0.22 µm PTFE or PES depending on solvent), and dilute into the working buffer immediately before use.
• Screen compatibility with typical buffers used in biochemical assays: PBS (pH 7.4), HEPES (pH 7.0–7.5), Tris (pH 7.5–8.0), and acetate (pH 4.5–5.5). Monitor for precipitation or turbidity.
• If pH sensitivity is suspected, bracket pH during method development and verify activity/readout stability over the experimental time course.
• For LC–MS–coupled assays, prefer volatile buffers (ammonium formate/acetate, pH 3–8) to maintain instrument compatibility.

Note: Without item-specific data, do not assume buffering capacity or chelation properties. Refer to the CoA/Spec Sheet for any provided solubility or stability details.

Green Alternatives

Without structural and process context for Teprosulvose, green-chemistry guidance focuses on solvent and process choices surrounding its use rather than on the compound itself.

Greener handling strategies (general):

• Prefer water, ethanol, or isopropanol over chlorinated or high-toxicity solvents when formulating stocks or cleaning equipment—provided the compound is compatible.
• Use minimal DMSO concentrations in biological assays (≤0.1–0.5% v/v) to reduce solvent burden and cytotoxic confounders.
• Implement microscale workflows (96/384-well formats) to reduce material and solvent consumption.
• Choose volatile buffers (ammonium acetate/formate) for LC–MS compatibility, enabling solvent recycling and reducing salt waste.

Illustrative comparison (solvent context):

• DMSO (benchmark for solubility and stability) vs. ethanol/water co-solvent systems:
  • DMSO: excellent solvating power; not inherently green; can affect biology at >0.5%.
  • EtOH/H2O: greener, lower toxicity; may limit solubility for hydrophobic analytes but suitable for many polar bioreagents.

Waste minimization:

• Consolidate aqueous waste streams; segregate organic waste; label unknowns clearly pending SDS hazard classification.
• Use closed-vial aliquoting to extend shelf life and reduce repeat synthesis or procurement, thereby lowering environmental impact.

Pharmaceutical Uses

No pharmacopeial status or excipient role is provided for Teprosulvose. This product is supplied strictly for research use only and is not intended for human or veterinary administration.

General information (non-clinical, process-focused):

• If used in pre-formulation research, establish solubility, stability (pH, light, temperature), and compatibility with common excipients experimentally.
• Determine hygroscopicity and solid-state form (amorphous vs. crystalline) where relevant to formulation research; utilize DSC/TGA and PXRD for characterization.
• For analytical development, validate methods (specificity, linearity, accuracy, precision) in accordance with internal QA expectations; do not infer regulatory suitability without formal qualification.

Important: No therapeutic, diagnostic, or clinical claims are made or implied for this product. Consult your institutional review and EHS requirements for handling investigational research materials.

Physical Properties

Item-specific physicochemical properties are not provided in the current listing.

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
• Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
• Density: Not specified for this item; refer to CoA/Spec Sheet.
• Solubility: Not specified for this item; refer to CoA/Spec Sheet.
• LogP/LogD: Not specified for this item; refer to CoA/Spec Sheet.
• pKa: Not specified for this item; refer to CoA/Spec Sheet.
• Refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Practical guidance (general, method-development oriented):

• When properties are unknown, perform a small-scale solubility screen in common lab solvents compatible with your application (e.g., water, PBS, methanol, ethanol, acetonitrile, isopropanol, DMSO). Begin at 1–10 mg/mL, agitate, and visually inspect; verify by UV or LC.
• If LC–MS is planned, start with a reversed-phase gradient (water + 0.1% FA / acetonitrile + 0.1% FA) and monitor for ionization in ESI±. Adjust buffers based on observed retention and ionization efficiency.
• For hygroscopic or amorphous materials, weigh quickly in a low-humidity environment and use pre-dried vials.

Note: Definitive specifications must be taken from the item’s CoA/Spec Sheet; the above are general laboratory practices, not item-specific values.

Quality and Grades

Grade and purity are not specified for this item in the current listing.

• Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret and evaluate quality (general guidance):

• If supplied as a research-grade small molecule or bioreagent, typical CoA elements may include identity (NMR/HRMS/LC–MS), purity (HPLC/UPLC), residual solvents, water content (KF), and, where relevant, counterion/ash content. Verify acceptance criteria match your application.
• For chromatography-critical work (biochemical assays, screening), request lots with HPLC purity ≥95–98% and clearly stated analytical methods.
• If the material is moisture- or light-sensitive, confirm packaging (amber glass, desiccant, inert gas flush) and any stabilizers. If a stabilizer is present, ensure it is compatible with downstream assays.
• Batch-to-batch control: For quantitative biology, confirm reported potency or activity where applicable; for small molecules, check LC retention time and spectral fingerprints across lots.

Documentation:

• Request the latest CoA and, if needed, a Spec Sheet or Methods Summary detailing analytical conditions. Use the CoA as the only authoritative source for item-specific specifications.

Reaction and Applications

Manufacturer-provided application details are not available for Teprosulvose. In the absence of structural and reactivity information, synthetic reaction guidance cannot be specified for this item.

General research use contexts (non-clinical):

• If Teprosulvose is a small-molecule bioreagent, typical applications may include target engagement studies, pathway interrogation in cell-free or cell-based systems, or use as a reference control in analytical methods. These examples are generic and should be verified against the item’s CoA/SDS and any available technical note.

Good laboratory practice for uncertain reactivity:

• Before coupling or derivatization, establish chemical stability in proposed reaction media (acid/base, nucleophiles, oxidants/reductants) using micro-scale tests and LC–MS monitoring.
• If proceeding with bioconjugation or labeling workflows, first determine presence/absence of reactive handles (e.g., amine, carboxyl, thiol, carbonyl) via spectroscopic or derivatization assays; do not assume functionality.
• For analytical applications (e.g., calibration, internal standard), validate purity and response factors across instruments.

Important: Do not extrapolate reactivity or mechanism without structure. Contact Technical Support for any available application notes or literature references specific to this CAS.

Reaction Conditions

No reaction condition guidance is available for Teprosulvose due to absent structural information.

General development heuristics (if chemistry is pursued):

• Start with mild, chemoselective conditions targeting common functionalities (e.g., EDC/NHS coupling for carboxylates, SuFEx for sulfonyl fluorides, or reductive amination for aldehydes/ketones) only after confirming the corresponding groups are present.
• Use small-scale (≤0.05 mmol) scouting with LC–MS monitoring to establish compatibility windows for solvent, temperature (0–50°C), and pH.
• Prefer mixed aqueous/organic systems (buffer/MeCN or buffer/MeOH) for bioconjugation-like transformations; exclude oxygen/moisture only if necessary.
• For purification, employ reversed-phase chromatography with volatile modifiers (0.1% formic acid or ammonium acetate) to facilitate solvent removal and MS detection.

Note: Expected yields, catalyst loads, and kinetics are inherently structure-dependent and cannot be generalized to this item without further data. Consult the CoA/Spec Sheet or request structural information before planning synthetic transformations.

Safety and Handling

Safety information specific to Teprosulvose is not available in the provided data.

• Signal Word: Not specified for this item; refer to SDS.
• GHS Classification: Not specified for this item; refer to SDS.
• H-Statements / P-Statements / Pictograms: Not specified for this item; refer to SDS.
• Research Use: For research use only. Not for human or veterinary use.

General laboratory precautions (good practice):

• Wear appropriate PPE: lab coat, safety glasses, and suitable gloves. Handle powders in a fume hood or ventilated enclosure to minimize inhalation exposure.
• Avoid contact with skin and eyes; prevent aerosol/dust generation. Wash hands thoroughly after handling.
• Until incompatibilities are known, segregate from strong oxidizers/reducers and acids/bases; avoid metal-catalyzed degradation if the chemistry is unknown.
• If dissolved in organic solvent (e.g., DMSO), follow solvent-specific hazard controls.

First-aid overview (defer to SDS for authoritative instructions):

• Inhalation: Move to fresh air; seek medical advice if symptoms persist.
• Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; obtain medical attention if irritation develops.
• Ingestion: Rinse mouth; do not induce vomiting unless directed by medical personnel; seek medical attention.

Spill and disposal:

• Contain and collect with inert absorbent; dispose of according to institutional and local regulations. Always consult the SDS for definitive hazard and response guidance.

Solvent Selection

Solubility data for Teprosulvose are not provided. The optimal solvent system depends on its (unknown) polarity, ionization, and functional groups.

Practical screening workflow (general):

• Start with small-scale trials (1–5 mg) in: water, PBS (pH 7.4), methanol, ethanol, isopropanol, acetonitrile, acetone, and DMSO. Heat gently (≤40–50°C) and sonicate if compatible. Record qualitative solubility and clarity.
• If partial solubility is observed, consider co-solvent systems: water/DMSO, water/MeCN, or buffered aqueous media (pH 5–9). Titrate pH only if the compound is known to be stable across the range.
• For biological assays, DMSO stocks (10–100 mM) diluted into assay buffer to ≤0.1–0.5% DMSO v/v are commonly used to balance solubility and bio-compatibility.

Notes and tradeoffs:

• Avoid non-volatile buffers if LC–MS analysis is required; use volatile modifiers (0.1% FA, 10 mM ammonium formate/acetate) for method compatibility.
• If the compound is amphiphilic or surfactant-like, micellization can affect apparent solubility; dynamic light scattering (DLS) can help detect aggregates.
• Protect from hydrolysis and oxidation until stability is characterized; prepare fresh working solutions as needed.

Storage and Reconstitution

Item-specific storage and shipping details are provided; reconstitution parameters are not.

• Storage Conditions (from Product Data): Store at −20°C.
• Shipped In (from Product Data): Ice chest + Ice pads.
• Appearance: Not specified for this item; refer to CoA/Spec Sheet.

General best practices:

• Upon receipt, inspect the container for integrity and allow to equilibrate to room temperature in a desiccator before opening to minimize condensation, especially if hygroscopic.
• If supplied as a solid, prepare single-use aliquots after initial opening. If supplied in solution, aliquot into inert, tightly sealed vials to minimize freeze–thaw cycles.
• Common reconstitution approaches (if compatible):
  • For biological assays: prepare a concentrated stock in DMSO or water; filter through 0.22 µm if sterility is required and solvent-compatible.
  • Record solvent, concentration, and date on each aliquot; store working stocks at −20°C or as stability data permit.
• Protect from light if chromophore presence is suspected; use amber vials as a precaution until stability is known.

Shelf life and stability:

• Specific stability, freeze–thaw tolerance, and permissible storage durations are Not specified for this item; refer to CoA/Spec Sheet.
• Always follow institutional SDS guidance and dispose of expired material appropriately.

Research Use Note: For research use only.

Structure and Identity

Brief overview: Teprosulvose (SKU: T1444392) is listed under Life Science research reagents. Item-specific structural identifiers are not provided in the current listing.

• Product Name: Teprosulvose
• SKU: T1444392
• CAS: 1983131-47-0
• Category Path: 全部 / 可售 / 生命科学
• Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
• SMILES: Not specified for this item; refer to CoA/Spec Sheet.
• InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

• Functional groups, ring systems, heteroatoms, and stereochemical elements are not available in the current product data.
• Without a structure, predictions of ionization state, polarity, and H-bonding capacity cannot be asserted. Users should consult the CoA/SDS or request structural documentation from Technical Support for informatics work (e.g., docking, property prediction, LC–MS method development).

Note on representation:

• 2D/3D depictions, canonical SMILES, and InChI are essential for method development and should be verified against the supplier’s latest CoA or certificate of identity if required for regulated workflows.

Synthetic Utility

Synthetic utility cannot be defined without structural information. The current product data do not disclose functional groups or reactive sites for Teprosulvose.

General guidance if pursuing derivatization (hypothesis-driven):

• Establish identity and purity by orthogonal methods (NMR, HRMS, HPLC/UPLC). If a chromophore is absent, consider ELSD/CAD for purity assessment.
• Map potential reactive handles via micro-derivatization screens (e.g., acylation for amines/alcohols, reductive amination for carbonyls, carbodiimide coupling for acids) and analyze by LC–MS to infer functionality.
• If bioconjugation is intended, assess stability toward maleimide/thiol or NHS-ester/amine chemistry with small model reagents before scaling.
• Avoid strong conditions (concentrated mineral acids/bases, high temperatures) until decomposition pathways are understood.

Conclusion: Without item-specific structural details, plan workups and purifications to be broadly compatible (e.g., reversed-phase flash/prep LC, SPE cleanup) and confirm identity at each step.

Target Specificity

Target specificity data are not provided for Teprosulvose. No antigen/epitope, enzyme, receptor, isoform, or organism selectivity information is available in the current listing.

• If this product is an antibody, protein, or targeted probe, please consult the CoA/Spec Sheet for clone, isotype, host species, and validated reactivity. None of these details are specified here.
• If it is a small molecule, no selectivity or binding data are available; do not assume target class or potency.

Conclusion: This section is not applicable without product-specific targeting information. Contact Technical Support with the SKU (T1444392) and CAS (1983131-47-0) for any available validation data.